Invention Grant
- Patent Title: EP2 receptor agonists for treating glaucoma
- Patent Title (中): 用于治疗青光眼的EP2受体激动剂
-
Application No.: US11472145Application Date: 2006-06-21
-
Publication No.: US07696235B2Publication Date: 2010-04-13
- Inventor: David F. Woodward , June Chen
- Applicant: David F. Woodward , June Chen
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agency: Allergan, Inc.
- Agent Kevin J. Forrestal; John E. Wurst
- Main IPC: A61K31/44
- IPC: A61K31/44 ; C07D213/62
Abstract:
The present invention relates to novel EP2 Receptor agonists that are useful for treating glaucoma and other conditions and indications in man. Ocular hypotensive agents are useful in the treatment of a number of various ocular hypertensive conditions, such as post-surgical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts.
Public/Granted literature
- US20070049625A1 EP2 receptor agonists for treating glaucoma Public/Granted day:2007-03-01
Information query
